cho_logo_symbol_border

Month: September 2022

“Game-changer” Paxlovid turns into pandemic enigma

“Paxlovid, once hailed as a “game-changer” for its ability to treat COVID-19 infections at home, is becoming one of the pandemic’s biggest enigmas. The intrigue: There’s growing concern about the link between Pfizer’s antiviral pill and COVID rebound, in which patients test positive or have symptoms days after a

Read More

A third COVID Autumn is Upon Us

Each new season brings new hope of a possible end to the pandemic, but forecasts say we should not be celebrating yet. “As the country heads for its third autumn and winter with Covid-19, the forecasts are not auspicious. Given how transmissible the SARS-CoV-2 virus is, models anticipate more

Read More

 

Our Journey to $1B+ Valuation

 

Disrupting Healthcare Testing / Diagnostics Early Detection of Cancer,
Chronic Conditions, Disease, Unlocking Anti-Aging Genomics & Promoting Longevity.

 

FUNDING GOAL $20,000,000

Funding Goal $20,000,000

20%

Skip to content